Latest Breaking News On - Xeris careconnection - Page 1 : comparemela.com

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings Inc sees FDA grant Orphan-drug exclusivity to Recorlev for treatment of Cushing's syndrome

Xeris Biopharma Holdings (NASDAQ:XERS) Inc revealed that the Food and Drug Administration (FDA) granted its subsidiary Xeris Pharmaceuticals Inc,.

Xeris Biopharma Holdings, Inc. (XERS) CEO Paul Edick on Q1 2022 Results - Earnings Call Transcript

Xeris Biopharma Holdings, Inc. (NASDAQ:NASDAQ:XERS) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Allison Wey - SVP, IR & Corporate Communications Paul.

Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events

CHICAGO (BUSINESS WIRE) May 11, 2022

Recorlev Now Available for Endogenous Hypercortisolemia in Cushing Syndrome

Recorlev (levoketoconazole) is now available for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome.